πŸ‡ΊπŸ‡Έ FDA
Patent

US 8183282

Therapeutic uses of urolithins

granted A61KA61K31/195A61K31/35

Quick answer

US patent 8183282 (Therapeutic uses of urolithins) held by The Regents of the University of California expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/195, A61K31/35, A61P, A61P35/00